Patents by Inventor Frederick R. Cahn

Frederick R. Cahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6620621
    Abstract: This invention teaches a method to identify cellular abnormalities which are associated with disease states. The method utilizes infrared (IR) spectra of cell samples which are dried on an infrared-transparent matrix and scanned at the frequency range from 3000-950 cm−1. The identification of samples is based on establishing a reference using a representative set of spectra of normal and/or diseased specimens. During the reference assembly process, multivariate techniques such as Principal Component Analysis (PCA) and/or Partial Least Squares (PLS) are used. PCA and PLS reduce the data based on maximum variations between the spectra, and generate clusters in a multidimensional space representing the different populations. The utilization of Mahalinobis distances, or linear regression (e.g., Principle Component Regression on the reduced data from PCA) form the basis for the discrimination.
    Type: Grant
    Filed: November 3, 1999
    Date of Patent: September 16, 2003
    Assignee: Digilab
    Inventors: Menashi A. Cohenford, Prashant S. Bhandare, Frederick R. Cahn, Krishnaswamy Krishnan, Basil Rigas
  • Patent number: 6031232
    Abstract: This invention discloses a method to identify premalignant and malignant stages of cervical cancer from an infrared (IR) spectrum of exfoliated cervical cells which are dried on an infrared transparent matrix and scanned at the frequency range from 3000-950 cm.sup.-1. The identification of samples is based on establishing a calibration using a representative set of spectra of normal, dysplastic and malignant specimens. During the calibration process, multivariate techniques such as Principal Component Analysis (PCA) and/or Partial Least Squares (PLS) are used. PCA and PLS reduce the data based on maximum variations between the spectra, and generate clusters in a multidimensional space representing the different populations. The utilization of Mahalinobis distances, or linear regression (e.g., Principle Component Regression on the reduced data from PCA) form the basis for the discrimination.
    Type: Grant
    Filed: November 13, 1995
    Date of Patent: February 29, 2000
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Menashi A. Cohenford, Prashant S. Bhandare, Frederick R. Cahn, Krishnaswamy Krishnan, Basil Rigas
  • Patent number: 5976885
    Abstract: This invention teaches a method to identify cellular abnormalities which are associated with disease states. In one aspect, the invention is a method to distinguish premalignant and malignant stages of cervical cancer from normal cervical cells. The method utilizes infrared (IR) spectra of exfoliated cervical cells which are dried on an infrared transparent matrix and scanned at the frequency range from 3000-950 cm.sup.-1. The identification of samples is based on establishing a calibration using a representative set of spectra of normal, dysplastic and malignant specimens. During the calibration process, multivariate techniques such as Principal Component Analysis (PCA) and/or Partial Least Squares (PLS) are used. PCA and PLS reduce the data based on maximum variations between the spectra, and generate clusters in a multidimensional space representing the different populations. The utilization of Mahalinobis distances, or linear regression (e.g.
    Type: Grant
    Filed: November 12, 1996
    Date of Patent: November 2, 1999
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Menashi A. Cohenford, Prashant S. Bhandare, Frederick R. Cahn, Krishnaswamy Krishnan, Basil Rigas